XTX Topco’s Anbio Biotechnology NNNN Stock Holding History

XTX Topco’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,896	Closed	-$257K	–	3959
2025 Q3	$257K	Buy	+6,896	New	+$310K	0.01%	1627

Other funds holding NNNN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's NNNN Position: Q4 2025 in Review

XTX Topco sold out of Anbio Biotechnology (NNNN) in Q4 2025, closing a stake of 6,896 shares — an estimated $257K sold.

XTX Topco first reported a position in NNNN in Q3 2025 and held it in 1 quarter. The position peaked at $257K in Q3 2025. 5 funds tracked by Wall St. Rank hold NNNN as of Q4 2025.

XTX Topco reported no remaining Anbio Biotechnology position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 6,896 Anbio Biotechnology shares in Q4 2025, an estimated $257K.
XTX Topco first reported a position in Anbio Biotechnology in Q3 2025 and held it in 1 quarter.
XTX Topco's Anbio Biotechnology position peaked at $257K in Q3 2025.
5 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.